Activation-induced colocalisation of SCAMP5 with IFNα in human plasmacytoid dendritic cells

Lupus Sci Med. 2022 Mar;9(1):e000680. doi: 10.1136/lupus-2022-000680.

Abstract

Introduction: Plasmacytoid dendritic cells (pDCs) are the main producers of type I interferon (IFN) in SLE. pDCs express high secretory carrier membrane protein 5 (SCAMP5). Recent work in transfected HEK cells connects SCAMP5 to the type I IFN secretory pathway. To further study the role of SCAMP5 in IFNα secretion by pDCs, we focused on the subcellular distribution of SCAMP5 in human pDCs freshly isolated from peripheral blood.

Methods: We measured SCAMP5 expression by flow cytometry in peripheral blood mononuclear cells of healthy subjects (n=8). Next, we assessed the colocalisation of SCAMP5 with IFNα in pDCs of healthy subjects (n=4) by evaluating bright detail similarity (BDS) scores using ImageStream technology.

Results: We confirm that SCAMP5 is highly expressed by pDCs derived from peripheral blood. In activated pDCs, we show that SCAMP5 colocalises with IFNα (mean BDS 2.0±0.1; BDS >2.0 in 44% of pDCs).

Conclusion: SCAMP5 colocalises with IFNα in activated human pDCs, in support of a role of this trafficking protein in the secretion of type I IFN by pDCs.

Keywords: autoimmunity; interferon type I; lupus erythematosus, systemic.

Publication types

  • Letter

MeSH terms

  • Dendritic Cells / metabolism
  • Humans
  • Interferon Type I*
  • Interferon-alpha / metabolism
  • Leukocytes, Mononuclear / metabolism
  • Lupus Erythematosus, Systemic*
  • Membrane Proteins / metabolism

Substances

  • Interferon Type I
  • Interferon-alpha
  • Membrane Proteins
  • SCAMP5 protein, human